Citation Impact
Citing Papers
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
2006 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting
1999
Indications for referral and assessment in adultliver transplantation: a clinical guideline
1999
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
2010
Which is the best surgery for budd-chiari syndrome: Venous decompression or liver transplantation? a single-center experience with 50 patients
1995
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting
2002
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Acute kidney injury
2012 Standout
Heterogeneity of growth potential of adult rat hepatocytes in vitro
2000
Portosystemic Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis: Clinical, Laboratory, Psychometric, and Electroencephalographic Investigations
1998
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
1999
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Fatty Infiltration of Liver in Hyperlipidemic Patients
2000
Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy
2000
Budd–Chiari syndrome: a review by an expert panel
2003
Mesenchymal cells in the liver – one cell type or two?
2002
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
2005
Bone Tissue Engineering: State of the Art and Future Trends
2004 Standout
Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome
2001
Hepatic Progenitors and Strategies for Liver Cell Therapies
2001
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
1998
The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites
1995
Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population‐based study
2009
Current Management of Vascular Access
2007
Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study.
2001
Nonalcoholic Fatty Liver Disease
2002 Standout
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation
2006
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis
2017
Antithrombotic Therapy for VTE Disease
2016 Standout
Liver-specific gene expression in mesenchymal stem cells is induced by liver cells
2005
Percutaneous Transhepatic Hepatic Venography in the Delineation and Treatment of Budd-Chiari Syndrome
1996
Treatment of Hepatic Encephalopathy
1997
PORTAL SYSTEMIC ENCEPHALOPATHY
1997
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy
2002
Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis
2003
An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Interventional therapeutic techniques in Budd-Chiari syndrome
1997
EuroSCORE II
2012 Standout
Stem cells find their niche
2001 StandoutNature
Vasoactive substances in the circulatory dysfunction of cirrhosis
2001
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
1999
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
2009
Prevalence of Spontaneous Portosystemic Shunts in Patients With Portopulmonary Hypertension and Effect on Treatment
2011
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature
2003
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Acute Mesenteric Ischemia
2004 Standout
Isolation, Characterization, and Transplantation of Bone Marrow-Derived Hepatocyte Stem Cells
2001
The Use of E/A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt
2009
Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis
2012
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data
2007
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm
2003 StandoutNobel
The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club
2003
Portal hypertensive bleeding in cirrhosis
2016 Standout
Gastroesophageal Variceal Hemorrhage
2001
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
2000
Hereditary Hemorrhagic Telangiectasia: Multi–Detector Row Helical CT Assessment of Hepatic Involvement
2004
Psychiatric Aspects of Portal-Systemic Encephalopathy
1998
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
Use of Transjugular Intrahepatic Portosystemic Shunts during Lytic Therapy of Extensive Portal Splenic and Mesenteric Venous Thrombosis: Long-term Follow-up
2000
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Percutaneous balloon angioplasty of inferior vena cava in Budd–Chiari syndrome-R1
2002
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
The Utility of TIPS in the Management of Budd-Chiari Syndrome
2005
Transcatheter Thrombolytic Therapy for Acute Mesenteric and Portal Vein Thrombosis
2005
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
2000
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review
2011
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Reassessing the role of medical therapy in the management of hepatic vein thrombosis
1997
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Nonalcoholic fatty liver disease
2005 Standout
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
2005
Radiological intervention in budd-chiari syndrome: Techniques and outcome in 18 patients
1996
Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts
2008
Repeat Interventions for Maintenance of Transjugular Intrahepatic Portosystemic Shunt Function in Patients with Budd-Chiari Syndrome
2002
Acute Budd–Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt
2004
Stem cells in adult tissues
2002
Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents
2003
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review
2011
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Transjugular Intrahepatic Portosystemic Shunt for the Management of Severe Venoocclusive Disease Following Bone Marrow Transplantation
1996
Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis
2010
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
2002
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Budd-Chiari Syndrome: Current Management Options
2001
The Myofibroblast
2007 Standout
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Budd–Chiari syndrome: Long‐term effect on outcome with transjugular intrahepatic portosystemic shunt
2005
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Identification and behavior of epithelial stem cells in the Drosophila ovary
1995
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis
2005
Management of Refractory Hepatic Encephalopathy After Insertion of TIPS: Long-Term Results of Shunt Reduction With Hourglass-Shaped Balloon-Expandable Stent-Graft
2009
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
2008 Standout
Cardiac volume overload and pulmonary hypertension in long‐term follow‐up of patients with a transjugular intrahepatic portosystemic shunt
2016
Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?
1996 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari Syndrome or portal vein thrombosis Review of indications and problems
1999
Randomized clinical trial of selective versus routine preoperative duplex ultrasound imaging before arteriovenous fistula surgery
2014 StandoutNobel
Works of A. Ochs being referenced
Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt
1999
Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis.
1995
Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension.
1999
Hepatic Progenitor Populations in Embryonic, Neonatal, and Adult Liver
1993
Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome
1993
The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure.
1995
Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt.
1995
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
1997
Transjugular Intrahepatic Portosystemic Shunt (Tips)
1997
Clinical relevance of abnormal liver findings with ultrasound.
1994
Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
1999